Mastopexy Market Size, Share, Growth & Forecast by Technique, End Use, Country and Company Analysis, 2026–2034

Buy Now
Excel: 8 Hours
PDF: 24 Hours
Mar 2026
Pages: 200

FAQs

The global mastopexy market is projected to grow from US$1.82 billion in 2025 to US$2.98 billion by 2034, registering a 5.62% CAGR during 2026–2034. Growth is supported by increasing demand for cosmetic and reconstructive breast procedures, greater awareness of aesthetic surgery, surgical advancements, rising disposable income, and growing acceptance of cosmetic procedures.

Mastopexy, commonly known as a breast lift, is a cosmetic surgical procedure designed to lift and reshape sagging breasts. The procedure may involve removing excess skin and repositioning the nipple and areola to create a higher and more natural position. The report identifies aging, pregnancy, breastfeeding, weight fluctuations, and loss of skin elasticity as factors associated with breast sagging.

The major growth drivers include increasing demand for cosmetic and aesthetic procedures, advancements in surgical techniques and medical technology, rising disposable income, and the expansion of medical tourism. Increasing awareness and acceptance of cosmetic surgery are also supporting demand for mastopexy procedures.

The mastopexy market is segmented by Crescent Breast Lift, Benelli Lift, Benelli-Lollipop Lift, and Full Mastopexy. The Benelli technique is generally associated with mild sagging, while more comprehensive mastopexy procedures can address greater changes in breast shape and sagging

Mastopexy procedures are performed through hospitals and specialty clinics. Specialty clinics focus on aesthetic surgical procedures and may provide consultation and treatment plans, while hospitals can provide broader medical facilities, surgical teams, patient monitoring, and emergency healthcare services.

Key challenges include the high cost of cosmetic surgery and concerns about surgery-related risks. Patients may need to bear expenses for surgery, hospital services, anesthesia, and postoperative care. Potential risks can include infection, scarring, bleeding, anesthesia reactions, swelling, discomfort, and changes in breast sensitivity.

The report covers 25 countries across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Key markets discussed individually include the United States, United Kingdom, India, and Saudi Arabia, while the broader country analysis includes markets such as Canada, Germany, France, China, Japan, Australia, Brazil, Mexico, South Africa, and the United Arab Emirates.